Videos

Charise Gleason, MSN, NP-C, AOCNP, and Nikki Barkett, RN, BSN, OCN, discuss how they use a team approach to help patients remain on their multiple myeloma therapy and remain on therapy longer.

New treatments for multiple myeloma have brought hope to many patients and their families. However, some patients do not remain adherent to their therapy. Join our experts, Charise Gleason, MSN, NP-C, AOCNP, and Nikki Barkett, RN, BSN, OCN, as they discuss how they help patients understand the importance of remaining on their therapy.

Helping the patient’s caregiver understand their role in the NSCLC patient’s journey

Addressing common questions from NSCLC patients and their caregivers

Providing psychosocial support and counseling for NSCLC patients and their family

Educating patients about cancer- and treatment-related side effect management

Identification of new actionable targets and driver mutations have revolutionized the treatment of NSCLC

Waiting for biomarker test results ensures the best outcomes in NSCLC.

Describing the road map of the cancer care journey in NSCLC.

The use of targeted agents and immunotherapy has transformed the treatment of NSCLC